Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05619913
Title EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma (EPOCH)
Acronym EPOCH
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Australia New Zealand Gynaecological Oncology Group
Age Groups: senior | adult
Covered Countries GBR | CAN | AUS

No variant requirements are available.